12:00 AM
 | 
Sep 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Teflaro regulatory update

The European Commission approved an MAA from AstraZeneca for Zinforo ceftaroline to treat complicated skin and soft tissue infections (cSSTI) and community-acquired bacterial pneumonia (CABP). AstraZeneca...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >